Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Centerspace (NY: CSR )

70.81 +0.08 (+0.11%)
Streaming Delayed Price Updated: 11:22 AM EDT, Jul 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Centerspace

< Previous 1 2 Next >
Best-Performing REITs In April
Via Benzinga
Analyst Expectations For Center's Future
Via Benzinga
REITs Continue To Clobber Q1 Estimates
Via Benzinga
CSR Stock Earnings: Centerspace Beats EPS, Misses Revenue for Q1 2024
CSR stock results show that Centerspace beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
4 REITs That Have Beaten The Latest Correction
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Center
Via Benzinga
A Closer Look at 4 Analyst Recommendations For Centerspace
Via Benzinga
Analyst Ratings for Centerspace
Via Benzinga
Preview: Centerspace's Earnings
Via Benzinga
Four REITs That Just Raised Dividends
Via Benzinga
3 Top Inflation-Beating REITs You'll Regret Not Buying Soon
Prices of necessary commodities continue to rise persistently. The Labor Department stated that the consumer price index (CPI) increased 0.6% month over month in August. It’s the CPI’s biggest monthly... 
Via Talk Markets
3 REITS That Beat The Estimates On Forward Guidance
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023
Via Benzinga
Earnings Scheduled For February 20, 2024
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. 
Via Benzinga
Earnings Scheduled For October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter. 
Via Benzinga
Analyst Ratings for Centerspace
Via Benzinga
Earnings Scheduled For July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million. 
Via Benzinga
A Preview Of Centerspace's Earnings
Via Benzinga
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
Where Centerspace Stands With Analysts
Via Benzinga
What 4 Analyst Ratings Have To Say About Centerspace
Via Benzinga
Around $3M Bet On This Communication Services Stock? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed higher on Friday, there were a few notable insider trades. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 74 companies achieved new lows for the year. 
Via Benzinga
The 3 Best-Performing Residential REITs Over The Past 4 Weeks
Residential real estate investment trusts (REITs) were subpar performers in 2022, but like many other REITs, they are beginning to find their footing in 2023, as the entire residential subsector has... 
Via Benzinga
4 Analysts Have This to Say About Centerspace
Via Benzinga
What 4 Analyst Ratings Have To Say About Centerspace
Within the last quarter, Centerspace (NYSE:CSR) has observed the following analyst ratings: 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  OnFriday, 143 stocks hit new 52-week lows. 
Via Benzinga
Residential REIT Centerspace: From $107.50 to $60.16 In 12 Months
Shares of residential real estate investment trust (REIT) Centerspace (NYSE: CSR) sold with extraordinarily heavy volume and touched a brand new 52-week low.  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.